Explaining how systems like nanotechnology.

Related StoriesUsing integrated molecular pathology to manage incidental pancreatic cysts: an interview with Dr Ananya DasGenetic carrier screening: an interview with Don Hardison, CEO of Good Start GeneticsDiabetic retinopathy therapy innovations: an interview with Richard Kirk, CEO of Polyphotonix Alberta established fact for innovative typical energy applications, similarly, considerable investments in the advancement of health insurance and medical applications possess made the province a global leader in a bunch of medical applications, stated Ken Brizel, CEO of ACAMP.According to IMS data, the pharmaceutical market in Asia is expected to reach $350 billion in 2016, comprising approximately 30 % of the global pharmaceutical marketplace and driving close to 50 % of global, incremental growth through 2016. Regionally, Actavis has leading positions in Singapore, Indonesia, Hong Kong, New and Australia Zealand, and is quickly developing in Vietnam and Malaysia. Singapore supplies the ideal strategic area for Actavis' Asia Pacific headquarters, said Hordur Thorhallsson, Actavis' Senior Vice President, APACA.